<?xml version="1.0" encoding="UTF-8"?>
<p id="Par40">Moreover, multidrug-resistant (MDR)-
 <italic>Acinetobacter baumannii</italic> isolates carrying Cefotaxime-M (CTX-M) enzymes are now responsible for nosocomial infections and among specific populations and accountable for high mortality and morbidity [
 <xref ref-type="bibr" rid="CR105">105</xref>], as well as cholera O1 and O139 [
 <xref ref-type="bibr" rid="CR106">106</xref>â€“
 <xref ref-type="bibr" rid="CR109">109</xref>]. Additionally, it has been shown that the prevalence of MDR-TB among new TB cases increased from 12% in 2009 to 13.7% in 2010 in the EU. Thus, drug-resistant TB is still a major concern despite a decrease in TB incidence in subsequent years [
 <xref ref-type="bibr" rid="CR110">110</xref>, 
 <xref ref-type="bibr" rid="CR111">111</xref>].
</p>
